Prostate cancer treatment can wait for most men, Oxford study finds

Death from prostate cancer occurred in 3.1% of the active-monitoring group, 2.2% in the surgery group and 2.9% in the radiation group — differences considered statistically insignificant.

SHARE Prostate cancer treatment can wait for most men, Oxford study finds
This microscope image shows changes in cells indicative of adenocarcinoma of the prostate.

This microscope image shows changes in cells indicative of adenocarcinoma of the prostate.

Dr. Edwin P. Ewing Jr. / CDC via AP

Researchers have found long-term evidence that actively monitoring localized prostate cancer is a safe alternative to immediate surgery or radiation.

The results are encouraging for men who want to avoid treatment-related sexual and incontinence problems, according to Dr. Stacy Loeb, a prostate cancer specialist at NYU Langone Health who wasn’t involved in the research.

The study directly compared the three approaches — surgery to remove tumors, radiation treatment and monitoring. Most prostate cancer grows slowly, so it takes many years to look at the disease’s outcomes.

“There was no difference in prostate cancer mortality at 15 years between the groups,” Loeb said. And prostate cancer survival for all three groups was high — 97% regardless of treatment approach. “That’s also very good news.”

The results were published in the New England Journal of Medicine and presented at a European Association of Urology conference in Milan, Italy. Britain’s National Institute for Health and Care Research paid for the research.

Men diagnosed with localized prostate cancer shouldn’t panic or rush treatment decisions, said lead author Dr. Freddie Hamdy of the University of Oxford. Instead, they should “consider carefully the possible benefits and harms caused by the treatment options.”

A small number of men with high-risk or more advanced disease do need urgent treatments, Hamdy said.

The researchers followed more than 1,600 men in the United Kingdom who agreed to be randomly assigned to get surgery, radiation or active monitoring. The patients’ cancer was confined to the prostate, a walnut-sized gland that’s part of the reproductive system. Men in the monitoring group had regular blood tests, and some went on to have surgery or radiation.

Death from prostate cancer occurred in 3.1% of the active-monitoring group, 2.2% in the surgery group and 2.9% in the radiation group — differences considered statistically insignificant.

At 15 years, cancer had spread in 9.4% of the active-monitoring group, 4.7% of the surgery group and 5% of the radiation group.

The study was started in 1999, and experts said today’s monitoring practices are better, with MRI imaging and gene tests guiding decisions.

“We have more ways now to help catch that the disease is progressing before it spreads,” Loeb said.

In the United States, about 60% of low-risk patients choose monitoring, now called active surveillance.

Hamdy said the researchers had seen the difference in cancer spread at 10 years and expected it to make a difference in survival at 15 years, “but it did not.” He said spread alone doesn’t predict death from prostate cancer.

“This is a new and interesting finding, useful for men when they make decisions about treatments,” he said.

The Latest
He seems content to hand control over football operations and the Arlington Park stadium project to incoming president Kevin Warren, and as far as the likelihood of the Bears leaving Chicago, he says, “Change is necessary at times.”
Only 3% of ballots cast on Feb. 28 came from youth voters. So what’s the deal? “It’s obvious to me that young people in that city don’t feel empowered by their governance,” said Della Volpe, author of “Fight: How Gen Z is Channeling Their Fear and Passion to Save America.”
The Bears closed on the 326-acre former Arlington International Racecourse property last month and will decide in the coming months whether to pursue building stadium — in addition to hotels, shops and restaurants — on the property.
The feds’ key witness, former ComEd Vice President Fidel Marquez, spent hours testifying Tuesday about how he and other ComEd executives fielded constant requests to find jobs for people he said were pushed for employment by Madigan, even when evaluations found their qualifications lacking.
He will have to address the growing notion that investing in long-neglected South and West side neighborhoods comes at the expense of downtown and the North Side.